Validea Detailed Fundamental Analysis

Validea's guru fundamental report indicates that ELEVANCE HEALTH INC (ELV) receives a 79% rating based on their Low PE Investor model, which is based on the investment strategy of John Neff. The model identifies firms with persistent earnings growth trading at a discount, with ELV passing tests for P/E ratio, EPS growth, future EPS growth, sales growth, and free cash flow, but failing tests for total return/PE and EPS persistence. Neff's historical performance at Windsor Fund, outperforming the S&P 500 by 3.1% annually from 1964-1995, underscores the potential value in this investment approach.

Analysis

Elevance Health Inc. (ELV), a large-cap growth stock within the Insurance (Accident & Health) sector, received a 79% rating from Validea's Low PE Investor model, which is based on John Neff's investment strategy emphasizing persistent earnings growth and discounted valuation relative to earnings growth and dividend yield. This score is proximate to the 80% level that typically signifies model interest, with strong interest usually indicated above 90%. ELV passed key fundamental tests including P/E ratio, current EPS growth, future EPS growth projections, sales growth, and free cash flow, aligning with several positive aspects of the Neff strategy. However, the company did not meet the criteria for total return relative to its P/E ratio and, crucially for a Neff-inspired approach, failed on EPS persistence, indicating a potential weakness in the consistency of its historical earnings growth despite current positive growth indicators and free cash flow generation.

Key Decisions for Investors

• Investors should acknowledge ELV's strengths in current growth metrics, favorable P/E ratio, and robust free cash flow, but carefully weigh these against the model's identified weaknesses, particularly the lack of EPS persistence and a failing grade on total return relative to P/E.
• Given the 79% score from Validea's Neff model, which is just below the typical 80% threshold for initial interest, ELV warrants further due diligence, specifically focusing on the factors contributing to its inconsistent EPS track record and its total return potential before considering significant investment.
• For those following a Neff-like value-growth discipline, monitoring ELV for tangible improvements in earnings persistence and its total return/PE metric is advisable, as these are critical areas where the company currently falls short of the strategy's ideal profile.